Skip to main content
Livermore
Livermore
ZHEN

FMR LLC

SEC CIK
0000315066
Latest filing
Aug 13, 2026

SAGE holding history

Sage Therapeutics, Inc. in every 13F filed by FMR LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SAGE overviewAll 13F holders of SAGEFull Q2 2026 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of SAGE by FMR LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−4,133−100.0%Sold outHolders
Q2 20254,133$37.7K<0.1%−4,130−50.0%ReducedHolders
Q1 20258,263$65.7K<0.1%−4,108,743−99.8%ReducedHolders
Q4 20244,117,006$22.4M<0.1%−1,154,102−21.9%ReducedHolders
Q3 20245,271,108$38.1M<0.1%−552,248−9.5%ReducedHolders
Q2 20245,823,356$63.2M<0.1%−44,927−0.8%ReducedHolders
Q1 20245,868,283$110.0M<0.1%+385,806+7.0%AddedHolders
Q4 20235,482,477$118.8M<0.1%−2,213,578−28.8%ReducedHolders
Q3 20237,696,055$158.4M<0.1%−1,093,682−12.4%ReducedHolders
Q2 20238,789,737$413.3M<0.1%+1,706,204+24.1%AddedHolders
Q1 20237,083,533$297.2M<0.1%+532,042+8.1%AddedHolders
Q4 20226,551,491$249.9M<0.1%+233,957+3.7%AddedHolders
Q3 20226,317,534$247.4M<0.1%+340,441+5.7%AddedHolders
Q2 20225,977,093$193.1M<0.1%+345,568+6.1%AddedHolders
Q1 20225,631,525$186.4M<0.1%+140,951+2.6%AddedHolders
Q4 20215,490,574$233.6M<0.1%−146,510−2.6%ReducedHolders
Q3 20215,637,084$249.8M<0.1%−1,224,575−17.8%ReducedHolders
Q2 20216,861,659$389.8M<0.1%−1,895,630−21.6%ReducedHolders
Q1 20218,757,289$655.5M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.